Company Overview and News

173
CRH Medical: A Cheap, High-Quality Consolidator Of The GI Anesthesia Space

2018-06-21 seekingalpha
CRH Medical is a healthcare services company whose primary business is consolidating the gastroenterology anesthesia space in the United States.
CRH VRX HCA VRX CRHM GSK EXAS

36
4 Undervalued MedTech Stocks to Consider Amid Volatility

2018-06-19 investorplace
The U.S. medical device industry has exhibited strong and sustainable growth of late due to an aging population and increasing incidences of chronic and lifestyle diseases. The industry has also benefited from the increasing adoption of artificial intelligence (AI) and big-data applications, upbeat consumer sentiment and rising business investments.
ANIP CRH CPSI CRHM KMDA

36
4 Undervalued MedTech Stocks to Consider Amid Volatility

2018-06-19 zacks
The U.S. medical device industry has exhibited strong and sustainable growth of late due to an aging population and increasing incidences of chronic and lifestyle diseases. The industry has also benefited from the increasing adoption of artificial intelligence (AI) and big-data applications, upbeat consumer sentiment and rising business investments.
ANIP CRH CRHM KMDA

33
CRH Medical (CRHM) Shares March Higher, Can It Continue?

2018-05-02 zacks
As of late, it has definitely been a great time to be an investor in CRH Medical Corporation (CRHM - Free Report) . The stock has moved higher by 19.2% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
WFC WFCNP WFC.WS WFC.PRL CRHM WFC.PRJ WFC.PRT CRH WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

6
Sunniva: The Story Gets Better And Better

2018-05-02 seekingalpha
I had a chance to meet one-on-one with Dr. Anthony Holler, co-founder, Chairman and Chief Executive Officer and David Negus, Chief Financial Officer of Sunniva Inc.
SNNVF CRH LULU CRHM GSK

4
CRH Medical's (CRHM) CEO Edward Wright Company on Q1 2018 Results - Earnings Call Transcript

2018-05-02 seekingalpha
Welcome to the CRH Medical Q1 2018 Conference Call. As a reminder, all participants are in listen-only mode and the conference is being recorded. [Operator Instructions].
CRH CRHM

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to TSX:CRH / CRH Medical Corporation on message board site Silicon Investor.

Communications Research Inc. (CRHI) NCRH-Neurochemical Research
Coram (CRH)--has the turnaround begun CRH.V - Consolidated Rich Capital
Scriptel Holdings, Inc (SCRH)